Estrasorb is a drug owned by Exeltis Usa Inc. It is protected by 1 US drug patent filed in 2013 out of which all have expired. Based on its patents and exclusivities, its generic launch date is estimated to be Jan 31, 2015. Details of Estrasorb's patents and their expiration are given in the table below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| These drug patents focus on the other aspects of the drug like dosage, mode of administration (oral, tablet, capsules, liquids etc). | |||
| US5629021 | Micellar nanoparticles |
Jan, 2015
(9 years ago) |
Expired
|
US patents provide insights into the exclusivity only within the United States, but Estrasorb is protected by patents in multiple countries. Understanding the full scope of patent protection is crucial in strategizing market entry. By looking at the broader patent landscape, you can identify markets with weaker patent protection which could be ideal generic entry points. The following section offers details on Estrasorb's family patents as well as insights into ongoing legal events on those patents.
Estrasorb's Family Patents
Explore Our Curated Drug Screens
Generic Launch
Generic Release Date:
Estrasorb's generic launch date based on the expiry of its last outstanding patent is estimated to be Jan 31, 2015 (This date is subject to change depending upon the patent filing activities by the drug owner or exclusivity additions to its drug application)
Estrasorb Generics:
There are no approved generic versions for Estrasorb as of now.
About Estrasorb
Estrasorb is a drug owned by Exeltis Usa Inc. Estrasorb uses Estradiol Hemihydrate as an active ingredient. Estrasorb was launched by Exeltis Usa Inc in 2003.
Approval Date:
Estrasorb was approved by FDA for market use on 09 October, 2003.
Active Ingredient:
Estrasorb uses Estradiol Hemihydrate as the active ingredient. Check out other Drugs and Companies using Estradiol Hemihydrate ingredient
Dosage:
Estrasorb is available in emulsion form for topical use. Given below is detailed information on Dosage -
| Strength | Dosage Form | Availability | Application Pathway |
|---|---|---|---|
| 0.25% | EMULSION | Discontinued | TOPICAL |